EASL Wrap-up Session Highlighted Late-Breaking Clinical Data of First-in-class HBV-specific TCR T Cell Therapy (SCG101) Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma June 7, 2024 β 16:51
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference June 7, 2024 β 01:09
AI Zhipu AI Unveils New Products and Announces Further Price Cuts as GenAI Price Wars Deepen in China June 7, 2024 β 00:11
